Genome & Company, an immunotherapy developer, has taken the first to jump into the CDMO industry by acquiring a U.S. microbiome company, List Biological Laboratory (List Labs).At an online news conference on Wednesday, the company presented its mid-to-long-term vision of becoming a fully integrated
Sanofi-Aventis Korea has confirmed the safety and efficacy profile of Dupixent (ingredient: dupilumab) in treating children with uncontrolled moderate-to-severe atopic dermatitis in recent studies.The company conducted phase 2/3 LIBERTY AD PRESCHOOL clinical trials with 162 patients aged six months
JW Pharmaceutical’s anti-gout drug URC102 received certification from the European Patent Office (EPO) as a source technology.The patent is the company’s method to prepare a compound that works as the main ingredient and intermediate of URC102. URC102, developed as a new oral drug, inhibits uric aci
Novartis Korea has introduced its combination therapy of Piqray (ingredient: alpelisib) and fulvestrant, saying it could prolong the treatment period and overall survival (OS) of breast cancer patients with major genetic mutations.In May, the company’s breast cancer drug received approval from the M
The government decided to give reimbursement for CSL Behring’s hemophilia treatment, Abstilla, from June. SK Chemicals developed the original substance of the drug and transferred the technology to CSL Behring in 2009.The key developers of Abstilla separated from SK Chemicals and established TiumBio
Korea's drug regulators have recently notified that tofacitinib, baricitinib, and upadacitinib, used for treating rheumatoid arthritis, could increase the risk of heart-related severe events.The Ministry of Food and Drug Safety (MFDS) sent out letters about the increased risk of Pfizer's Xeljanz (in
The nation’s public health insurance assessment organ has decided to provide conditional reimbursement for Xospata (ingredient: gilteritinib) in treating leukemia patients.The Health Insurance Review and Assessment Service (HIRA) reviewed whether it is appropriate to cover health insurance for Xospa
A compound injection of acetaminophen plus ibuprofen recently received regulatory approval in Korea on Monday, marking the first landing of a unique double-action formulation for fast and effective pain relief.The Ministry of Food and Drug Safety (MFDS) approved KB Pharm to supply Maxigesic, the com
The public health authorities have concluded that the Covid-19 vaccines have no links to recently reported cases of acute leukemia, citing the opinions of hematological experts.Health officials said it is unnecessary to worry about leukemia after receiving the Covid-19 vaccine and recommended people
Samyang Biopharmaceuticals' U.S. subsidiary, Samyang Biopharm USA, is pushing to develop its cancer immunotherapy drug candidate, SYB-010, through global open innovation.Samyang Biopharm USA recently signed an agreement with the Spanish National Research Council, the largest public research institut
HLB said the company would present the two interim results of combination treatment of its rivoceranib with immune-oncology and cytotoxic antineoplastic drugs at the online World Conference on Lung Cancer (WCLC) 2021 on Sept. 13.The clinical results showed a 40 percent overall response rate (ORR), 9
Hanall Biopharma said its Chinese partner, Harbour BioMed, has received approval from China's National Medical Products Administration (NMPA) to conduct a phase 2 clinical trial of HL161 for chronic inflammatory demyelinating polyneuropathy.Harbour BioMed signed an agreement with Hanall Biopharma in
Domestic companies are jumping into the fray to develop therapies for stroke, like their multinational counterparts who have struggled to see significant results in their clinical trials.Actilyse (ingredient: alteplase), a tissue plasminogen activator (tPA) developed by Boehringer Ingelheim, is the
GSK and the German biopharmaceutical company CureVac said their second-generation mRNA Covid-19 vaccine demonstrated an improved immune response than the first generation, marking higher neutralizing antibody capacity against the variant strains.The preclinical study assessed the Covid-19 immune res
Vuno said Wednesday that its artificial intelligence-based solution reading chest X-ray image, VUNO Med-Chest X-ray, has obtained marketing approval from the Taiwan Food and Drug Administration (TFDA).The company signed an exclusive sales agreement with Taiwan’s CHC Healthcare Group (CHC), the large
KangStem Biotech said that it has signed a deal with Seoul National University’s R&DB Foundation to receive the university’s skin organoid manufacturing technology.The technology uses a three-dimensional (3D) air-liquid interface (ALI) skin organoid preparation from human pluripotent stem cells for
SK Bioscience has started administering Covid-19 vaccine candidate GBP510, jointly developed with the Institute for Protein Design (IPD) at the University of Washington, in phase 3 clinical trials.The company’s clinical trials are the first domestic phase 3 study of the Covid-19 vaccine approved by
Medpacto said that the U.S. Food and Drug Administration has granted an orphan drug designation (ODD) to the combination therapy of Vactosertib and PD-L1 inhibitors for treating osteosarcoma.Vactosertib received the FDA designation for the second time this year alone. Medpacto received orphan drug d
Novartis Korea presented a study on the treatment of Koreans with diffuse large B-cell lymphoma (DLBCL) patients and their financial burdens at an international conference last week.The company shared its findings identifying demographic characteristics, treatment patterns, and prognosis DLBCL patie
The number of workers in the healthcare industry, including medical staff and employees at pharmaceutical companies, rose in the second quarter from a year ago, a state agency said. In addition, workers at medical equipment makers showed a record-high increase while the cosmetics sector saw a drop i